Professor K. Ray Chaudhuri is a world-renowned expert in Parkinson's disease. He is Professor of Neurology/Movement Disorders & Consultant Neurologist at King’s College Hospital & King’s College London and also Principal Investigator at the Maurice Wohl Clinical Neuroscience Institute.
Dag Aarsland is Professor and Head of Department of Old Age Psychiatry at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, and Consultant psychiatrist at the Mental Health for Older Adults, South London & Maudsley NHS Health Trust, where he leads the Parkinson Spectrum Memory Clinic.
Healthcare Leading Team
Dr Areti Pavlidou, Consultant Psychiatrist specialising in Adult & Liaison Psychiatry; Lead Consultant for inpatient & community mental health services at NHS.
Healthcare Team of Collaborators
Partners & Collaborators
Dementech Neurosciences has been investing in research and has established a collaboration with the Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King’s College London for the development of novel biomarker tools for patients with Parkinson’s disease dementia and Alzheimer’s disease. The IoPPN at King’s College London is Europe’s largest centre for research and postgraduate education in psychiatry, psychology and neuroscience. King’s College London is one of the world’s leading research and teaching universities based in the heart of London.
Dementech Neurosciences has partnered with the Neurodegeneration Imaging Group, which is a world-leading group in neuroimaging development and applications in patients with neurodegenerative disorders such as Parkinson’s and Alzheimer’s disease. The Neurodegeneration Imaging Group develops and establishes a range of new projects and approaches for investigating aetiology, pathophysiology, diagnosis, progression, and identification of novel molecular targets for pharmacotherapy in neurodegenerative disorders.
Dementech Neurosciences is collaborating with the University of Oxford to further develop the Computerized Cognitive Rehabilitation and Psychotherapy (CCRP) technology which is the leading solution for Cognitive Rehabilitation and Psychotherapy technique for patients with cognitive symptoms. The University of Oxford it the oldest university in the English-speaking world and one of the leading universities in the world.
Dementech Neurosciences is collaborating with Alliance Medical for neuroimaging solutions. Alliance Medical are Europe’s leading independent provider of medical imaging services. They combine service excellence and innovative imaging technologies to improve patient care and support NHS and independent sector organisations with their ongoing imaging requirements.
Dementech Neurosciences is collaborating with Global Kinetics Corporation (GKC) which was established in 2007 to commercialise innovative technology for the precise recording, quantification and reporting of movement symptoms of neurological disease. The lead product, the Parkinson’s KinetiGraph™ movement recording is a unique and useful tool for neurologists in the management of Parkinson’s disease.
Dementech Neurosciences is collaborating with King’s Health Partners which is a leading Academic Health Science Centre where world-class research, education and clinical practice are brought together for the benefit of patients.
Dementech Neurosciences has partnered with The Doctors Laboratory (TDL), which is a medically-led laboratory, established in 1987. TDL is the largest independent provider of clinical laboratory diagnostic services in the UK.
Dementech Neurosciences is collaborating with University College London Hospitas NHS Foundation Trust which is committed to delivering top-quality patient care, excellent education and world-class research. The Trust is situated in the heart of London and is one of the largest NHS trusts in the United Kingdom.